Shanghai Pharma Leads China's Drug Market with $37 Billion Revenue

Shanghai Pharmaceuticals is the biggest drug importer in China and the second largest distributor of pharmaceuticals. Shanghai Pharmaceuticals generates $37 billion in total revenue and produces medications for cancer, diabetes, cardiovascular...

India's Pharma Industry to Hit $65B by 2024, Set to Double by 2030

India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030. CPHI & P-MEC India exemplifies this growth by connecting global and domestic stakeholders to showcase...

Aptar Empowers Indian Pharma with Inhalers, Nasal Sprays for Global Markets

Aptar is assisting Indian pharmaceutical firms in the launch of inhalers and nasal sprays for both local and export markets. Aptar is the top global supplier of inhalation devices, essential for administering medications used to manage respiratory...

AstraZeneca's US Investments Propel $80 Billion Revenue Goal by 2030

The US investments mark the initial phase of significant actions aimed at supporting AstraZeneca's goal of reaching $80 billion in overall revenue by 2030, as outlined in May of this year. An essential aspect of our approach is hastening the...

Price Drives Cardiac Growth in India's Top 10 Pharma Therapies

Among the leading 10 therapies that account for over 90% of the Indian pharmaceutical market, price was the key factor in the expansion of the cardiac sector. The anti-hypertensive medications, comprising nearly 50% of the cardiac sector, are...

India Ranks as Asia's 4th Largest Medical Devices Market, Eyes $50B by 2030

India is presently the fourth largest medical device market in Asia, boasting an industry valued at USD 14 billion and exports totaling USD 3.7 billion. The MedTech program is expected to assist local manufacturers in expanding the market value to...

Indian Pharma Market Grows 6.1% in October 2024

The Indian pharmaceutical market (IPM) experienced a 6.1 percent value increase in October 2024, with significant therapies demonstrating favorable value growth, as per a report from market research firm Pharmarack. Among these areas, the cardiac...

Unravelling India's Pharmaceutical Potential

In the ASSOCHAM Annual Pharma Summit 2024, Nakul Verma, Senior Director, Sanofi, shares industry analysis of the emerging pharmaceutical landscape. He pointed out India's outstanding potential in the pharmaceutical sector, focusing on the future's...

Pharma Industry deal value drops 69% in October 2024

In October 2024, the pharmaceutical sector disclosed 102 transactions worth $8.9 billion, representing a 69 percent decrease in deal value relative to October 2023. GlobalData reports that this deal activity also did not meet the average from the...

Laborie Secures New AMA CPT Code for Advanced Prostate Procedure

Laborie Medical Technologies Corp (Laborie), a top company in diagnostic and therapeutic medical technology, disclosed that the American Medical Association (AMA) has introduced the new Category 1 Current Procedural Terminology (CPT) code 52XX2...